Blog - Page 3 of 11 - Patient Focused Medicines Development
How patients’ voices can change drug approval
·

Consulting patients early and often can help regulators understand how medicines users view risk, benefit and quality of life The case of Lotronex (alosteron), a medicine for the management of severe irritable bowel syndrome (IBS), illustrates how patients can work with drug regulators to get the risk-benefit balance right. The story has echoes of Tysabri – a well-known multiple...

Read More

X